×

Novartis' precision M&A plan: CEO

6:12 AM ET Tue, 28 Oct 2014

We are focusing on three big divisions in the next five years - pharmaceuticals, generics and eye care., says Joe Jimenez, Novartis CEO, explaining how Novartis plans to benefit from partnering with other big pharma companies.